Ennature Bio Pharma Limited

NSE: ENNATURE

2

total announcements

ENNATURE.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 10 Nov 2026

Market Cap

₹458 Cr

EPS (TTM)

₹-0.00

52W Low

₹205.10

52W High

₹264.90

Dividend Yield

0.00%

Gross Margin

0.00%

Operating Margin

0.00%

NSETrading Window5d ago

Ennature Bio Pharma Limited

Trading Window

Ennature Bio Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Read more →📎 1 attachment
NSEPress Release▲ PositiveExpansion5d ago

Ennature Bio Pharma Limited

Press Release

Ennature Bio Pharma Limited listed on NSE and BSE on 4 November 2026, with a revenue of Rs 246 crore in FY26, driven by branded nutraceuticals. The company has three complementary businesses: plant-based pharmaceutical ingredients, biopolymers, and nutraceuticals.

Read more →📎 1 attachment